About Laurus Labs
Laurus Labs is a company based in Hyderabad (India) founded in 2005 by Subodh Singh. Laurus Labs has raised $229.73 million across 3 funding rounds from investors including Warburg Pincus, Aptuit and Eight Roads Ventures. The company has 12,470 employees as of March 31, 2024. Laurus Labs has completed 2 acquisitions, including Laurus Bio and Richcore Lifesciences. Laurus Labs operates in a competitive market with competitors including Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions, Jubilant Pharma and SeQuent, among others.
- Headquarter Hyderabad, India
- Employees 12470 as on 31 Mar, 2024
- Founders Subodh Singh
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Laurus Labs Ltd.
-
Annual Revenue
$650.1 M (USD)10.18as on Mar 31, 2025
-
Net Profit
$41.9 M (USD)123.18as on Mar 31, 2025
-
EBITDA
$126.88 M (USD)34.79as on Mar 31, 2025
-
Total Equity Funding
$229.73 M (USD)
in 3 rounds
-
Latest Funding Round
$89.73 M (USD), Private Equity Round
Oct 29, 2014
-
Investors
Warburg Pincus
& 2 more
-
Employee Count
12470
as on Mar 31, 2024
-
Investments & Acquisitions
Laurus Bio
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Laurus Labs
Laurus Labs is a publicly listed company on the NSE with ticker symbol LAURUSLABS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Laurus Labs
Unlock access to complete
Unlock access to complete
Funding Insights of Laurus Labs
Laurus Labs has successfully raised a total of $229.73M across 3 strategic funding rounds. The most recent funding activity was a Private Equity Round of $89.73 million completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Laurus Labs
Laurus Labs has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Warburg Pincus, Aptuit and Eight Roads Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Locked | Locked | Locked | |
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
Contract research and development services for small molecules are offered.
|
Locked | Locked | Locked |
Investor details for Laurus Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Laurus Labs
Laurus Labs has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Laurus Bio and Richcore Lifesciences.
Investment portfolio details for Laurus Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Precision fermentation services for biopharma and food are provided.
|
Locked | Locked | 2005 | Locked | |
|
Developer of enzymes for industrial solutions
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Laurus Labs
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Laurus Labs
Detailed financials for Laurus Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Laurus Labs Comparisons
Peer comparison for Laurus Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Laurus Labs
Laurus Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions, Jubilant Pharma and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
Detailed competitors of Laurus Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Laurus Labs
Complete news archive for Laurus Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laurus Labs
Laurus Labs was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Laurus Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Subodh Singh is the current CEO of Laurus Labs. They have also founded this company.
Laurus Labs is a funded company, having raised a total of $229.73M across 3 funding rounds to date.
As of Mar 31, 2024, the latest employee count at Laurus Labs is 12,470.
Annual revenue of Laurus Labs is $650.1M as on Mar 31, 2025.
Founded in 2005 and based in Hyderabad, India, operations are conducted in the pharmaceutical and biotechnology sectors. Active pharmaceutical ingredients are produced for antiretrovirals, hepatitis, oncology, cardiovascular, and anti-diabetic treatments. Generic formulations, custom synthesis solutions, veterinary APIs, and agro chemicals are also manufactured. Specialty ingredients for nutraceuticals, dietary supplements, and cosmeceutical products are developed.
Laurus Labs's top competitors include Symbiotec, Sterling Pharma Solutions and Provepharm Life Solutions.
Yes, Laurus Labs is publicly traded on NSE under the ticker symbol LAURUSLABS.
Laurus Labs has made 2 acquisitions, including Laurus Bio, and Richcore Lifesciences.
Laurus Labs has 3 investors. Key investors include Warburg Pincus, Aptuit, and Eight Roads Ventures.
The ticker symbol of Laurus Labs is LAURUSLABS on NSE.